340B Drug Pricing Program
Millions of Americans worry about the high costs of life-saving prescription drugs. That’s why 25 years ago, Congress created the 340B Drug Pricing Program to help hospitals expand access to prescription drugs and support essential services for our most vulnerable patients.
The program constitutes…
The Centers for Medicare & Medicaid Services Nov. 1 announced it will update the hospital outpatient prospective payment system rates by 1.35% in calendar year 2018 compared to CY 2017. The rule also finalizes CMS’s proposal to drastically cut Medicare payment for drugs that are acquired under…
On Nov. 1, the CMS released the calendar year 2018 outpatient prospective payment system/ambulatory surgical center final rule.
The Centers for Medicare & Medicaid Services today announced it will update the hospital outpatient prospective payment system rates by 1.35% in calendar year 2018 compared to CY 2017. The rule also finalizes CMS’s proposal to drastically cut Medicare payment for drugs that are acquired…
Press Release
Statement on Final CY 2018 OPPS Rule
Contact: Colin Milligan, 202-638-5491, cmilligan@aha.org
Marie Johnson, 202-626-2351, mjohnson@aha.org
Tom Nickels
Executive Vice President
American Hospital Association
November 1, 2017
The Health Resources and Services Administration has announced that 340B Drug Pricing Program hospitals in areas affected by recent natural disasters can immediately enroll in the program instead of waiting for the normal registration period. “HRSA recognizes that circumstances surrounding disaster…
The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing examining how covered entities use the 340B Drug Pricing Program. Established by Congress in 1992, the program mandates that drug manufacturers provide outpatient drugs to eligible health care…
The latest report from a group financed and backed by the pharmaceutical industry “continues to misrepresent” the 340B Drug Pricing Program and its “successful 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and…
The latest report from AIR340B, a group financed and backed by the pharmaceutical industry, continues to misrepresent a program with a successful 25-year history of helping hospitals stretch scarce financial resources to expand and improve access to lifesaving prescription drugs and comprehensive…